[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1383756T3 - Cumarinderivater til anvendelse som antikoagulanter - Google Patents

Cumarinderivater til anvendelse som antikoagulanter

Info

Publication number
DK1383756T3
DK1383756T3 DK02725817T DK02725817T DK1383756T3 DK 1383756 T3 DK1383756 T3 DK 1383756T3 DK 02725817 T DK02725817 T DK 02725817T DK 02725817 T DK02725817 T DK 02725817T DK 1383756 T3 DK1383756 T3 DK 1383756T3
Authority
DK
Denmark
Prior art keywords
compounds
taught
drawn
designed
analogs
Prior art date
Application number
DK02725817T
Other languages
English (en)
Inventor
Pascal Druzgala
Xiaoming Zhang
Jurg R Pfister
Original Assignee
Aryx Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aryx Therapeutics filed Critical Aryx Therapeutics
Application granted granted Critical
Publication of DK1383756T3 publication Critical patent/DK1383756T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02725817T 2001-04-24 2002-04-24 Cumarinderivater til anvendelse som antikoagulanter DK1383756T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28607901P 2001-04-24 2001-04-24
PCT/US2002/013163 WO2002085882A1 (en) 2001-04-24 2002-04-24 Coumarin derivatives to be used as anticoagulants

Publications (1)

Publication Number Publication Date
DK1383756T3 true DK1383756T3 (da) 2008-06-23

Family

ID=23096978

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02725817T DK1383756T3 (da) 2001-04-24 2002-04-24 Cumarinderivater til anvendelse som antikoagulanter

Country Status (12)

Country Link
US (2) US6864279B2 (da)
EP (1) EP1383756B1 (da)
JP (2) JP4662690B2 (da)
AT (1) ATE388143T1 (da)
AU (1) AU2002256361B2 (da)
CA (1) CA2445160A1 (da)
CY (1) CY1110261T1 (da)
DE (1) DE60225434T2 (da)
DK (1) DK1383756T3 (da)
ES (1) ES2301635T3 (da)
PT (1) PT1383756E (da)
WO (1) WO2002085882A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1383756T3 (da) * 2001-04-24 2008-06-23 Aryx Therapeutics Cumarinderivater til anvendelse som antikoagulanter
US7145020B2 (en) * 2001-04-24 2006-12-05 Aryx Therapeutics Materials and methods for treating coagulation disorders
JP2005525292A (ja) * 2001-08-24 2005-08-25 アリックス セラピューティクス 非酸化的に代謝される化合物および組成物、それらの合成経路、ならびに使用方法
CN1950353B (zh) 2004-04-08 2011-06-01 ARYx医疗有限公司 治疗凝血紊乱的药物和方法
ES2436298T3 (es) * 2004-04-08 2013-12-30 Armetheon, Inc. Materiales y procedimientos para el tratamiento de trastornos de la coagulación
DK2161261T3 (da) 2004-04-08 2013-11-04 Armetheon Inc Materialer og fremgangsmåder til behandling af koagulationslidelser
KR100794515B1 (ko) 2005-07-12 2008-01-16 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
WO2007008037A1 (en) * 2005-07-12 2007-01-18 Jeil Pharmaceutical Co., Ltd. Novel chromen-2-one based hydroxamic acid derivatives having anti-inflammatory activity, the preparation thereof and a composition containing the same for treating inflammatory disease
AU2007238548A1 (en) * 2006-01-30 2007-10-25 Caridianbct, Inc. Adjusting pH in a method of separating whole blood
AR059339A1 (es) 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
JP5325103B2 (ja) 2007-07-20 2013-10-23 中外製薬株式会社 ｐ２７蛋白質誘導剤
WO2010056914A1 (en) * 2008-11-12 2010-05-20 Microbiotix, Inc. Bacterial helicase inhibitor compounds and uses thereof
US9549912B2 (en) 2009-11-23 2017-01-24 Armetheon, Inc. Methods for treating atrial fibrillation
US20110136779A1 (en) * 2009-11-23 2011-06-09 Milner Peter G Methods for stroke reduction in atrial fibrillation patients
WO2011072275A2 (en) 2009-12-11 2011-06-16 Nono, Inc. Agents and methods for treating ischemic and other diseases
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465293A (en) * 1942-08-29 1949-03-22 Wisconsin Alumni Res Found Synthesis of 4-hydroxycoumarins
NL286657A (da) * 1961-12-19
BE626119A (da) * 1961-12-19
FR1463767A (fr) 1963-04-03 1966-07-22 Clin Byla Ets Dérivés de la coumarine et leur préparation
GB8531388D0 (en) * 1985-12-20 1986-02-05 Shell Int Research 4-hydroxycoumarin derivatives
JPS63165368A (ja) * 1986-01-07 1988-07-08 Yamanouchi Pharmaceut Co Ltd 新規複素環化合物およびその製造法
ES2065182T3 (es) * 1991-03-06 1995-02-01 Searle & Co Derivados de fenilamidinas utiles como inhibidores de la agregacion de plaquetas.
JPH0826011B2 (ja) * 1991-04-25 1996-03-13 アサヒビール株式会社 アミノメチルイソクロマン誘導体およびその製造方法
IL108459A0 (en) 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
JPH06340649A (ja) * 1993-05-31 1994-12-13 Lab Farmaceut Rovi Sa クマリンから誘導される新規な抗血栓剤及びその製造法
EP0632102B1 (de) * 1993-06-28 1997-04-02 Bayer Ag Massefärben von Kunststoffen
IL110172A (en) * 1993-07-22 2001-10-31 Lilly Co Eli Bicycle compounds and pharmaceuticals containing them
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
ZA965853B (en) * 1995-07-13 1998-01-12 Du Pont Merck Pharma Asymmetric synthesis of r and s warfarin and its analogs.
HUP9902256A3 (en) * 1995-12-29 2000-01-28 Dimensional Pharm Inc Amidino protease inhibitors and pharmaceutical compositions containing them
JP2000507588A (ja) * 1996-03-29 2000-06-20 ３―ディメンショナル ファーマシュウティカルズ，インコーポレイテッド プロテアーゼインヒビターとしてのアミジノヒドラゾン
FR2765579A1 (fr) * 1997-07-01 1999-01-08 Lipha Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones leurs preparations et leurs utilisations comme rodonticides
DK1383756T3 (da) * 2001-04-24 2008-06-23 Aryx Therapeutics Cumarinderivater til anvendelse som antikoagulanter
US7145020B2 (en) * 2001-04-24 2006-12-05 Aryx Therapeutics Materials and methods for treating coagulation disorders
CN1950353B (zh) * 2004-04-08 2011-06-01 ARYx医疗有限公司 治疗凝血紊乱的药物和方法
ES2436298T3 (es) * 2004-04-08 2013-12-30 Armetheon, Inc. Materiales y procedimientos para el tratamiento de trastornos de la coagulación

Also Published As

Publication number Publication date
ES2301635T3 (es) 2008-07-01
CA2445160A1 (en) 2002-10-31
AU2002256361B2 (en) 2008-01-24
US20080221204A1 (en) 2008-09-11
JP4662690B2 (ja) 2011-03-30
JP2004527547A (ja) 2004-09-09
ATE388143T1 (de) 2008-03-15
CY1110261T1 (el) 2012-05-23
DE60225434D1 (de) 2008-04-17
DE60225434T2 (de) 2009-03-12
US20030199573A1 (en) 2003-10-23
US6864279B2 (en) 2005-03-08
WO2002085882A1 (en) 2002-10-31
PT1383756E (pt) 2008-06-19
EP1383756B1 (en) 2008-03-05
JP2010143937A (ja) 2010-07-01
EP1383756A1 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
CY1110261T1 (el) Παραγωγα της κουμαρινης που χρησιμοποιουνται σαν αντιπηκτικα
BR0209320A (pt) ésteres de uridina farmaceuticamente ativos
BR9915727A (pt) ésteres derivados de compostos de fenil-ciclohexila substituìdos
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
BRPI0312464B8 (pt) compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos
AR011174A1 (es) Compuestos de pirazina, composiciones farmaceuticas que los contienen, su uso en la peparacion de medicamentos y proceso para prepararlos
NO20013367L (no) Colchinolderivater som vaskulorskadende midler
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
BR9810841A (pt) Inibidores de metaloprotease alicìclicos
CL2003002683A1 (es) Enantiomeros s de compuestos derivados del acido (2s)-3-4(-{2-amino-2-oxoetoxi}fenil)-2-etoxipropanoico; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos de lipidos,
EP1362846A4 (en) AMINOETHANOLDERIVATE
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
EA200301204A1 (ru) Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
TNSN07145A1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
BR0315580A (pt) Derivados de metileno uréia
BR0310077A (pt) Novos compostos e sua utilização
ATE327748T1 (de) Alkandiol derivate zur behandlung von knochenkrankheiten
DK1678162T3 (da) P-glycoprotein-inhibitor, fremgangsmåde til fremstilling heraf og farmaceutisk sammensætning omfattende denne
SE0402925D0 (sv) Novel Compounds
WO2003024943A3 (en) Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
PA8542601A1 (es) Bifenilcarboxamidas reductoras de lipidos
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
DK0525307T3 (da) Stabile præparater til parenteral indgivelse og deres anvendelse